COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,358 Articles (22,803 medRxiv, 8,555 bioRxiv)

Most recent first Previous |  Page 1046: Articles 10451-10460  | Next

Early estimates of SARS-CoV-2 Omicron variant severity based on a matched cohort study, Ontario, Canada
Ulloa, A. C., Buchan, S. A., Daneman, N., Brown, K. A.
10.1101/2021.12.24.21268382 — Posted: 2021-12-27 Discussion: Onsite
A model based on a high-resolution flux matrix explains the spread of diseases in a spatial network and the effect of mitigation strategies
Le Treut, G., Huber, G., Kamb, M., Kawagoe, K., McGeever, A., Miller, J., Pnini, R., Veytsman, B., Yllanes, D.
10.1101/2021.12.22.21268059 — Posted: 2021-12-27
Understanding the impact of the COVID-19 pandemic on a socially deprived UK coastal town: a preliminary exploratory analysis of health and socioeconomic data
French, M., Spencer, M., Walker, M., Patel, A., Clarke, N., Hughes, R., Taylor, C., Orwin, M., Elliott, A., Worsley, K., Casson, J., Milan, S., Bowen, M., Sedda, L.
10.1101/2021.12.22.21268232 — Posted: 2021-12-27
Wastewater sequencing uncovers early, cryptic SARS-CoV-2 variant transmission
Karthikeyan, S., Levy, J. I., De Hoff, P., Humphrey, G., Birmingham, A., Jepsen, K., Farmer, S., Tubb, H. M., Valles, T., Tribelhorn, C. E., Tsai, R., Aigner, S., Sathe, S., Moshiri, N., Henson, B., Hakim, A., Baer, N. A., Barber, T., Belda-Ferre, P., Chacon, M., Cheung, W., Crescini, E. S., Eisner, E. R., Lastrella, A. L., Lawrence, E. S., Marotz, C. A., Ngo, T. T., Ostrander, T., Plascencia, A., Salido, R. A., Seaver, P., Smoot, E. W., McDonald, D., Neuhard, R. M., Scioscia, A. L., Satterlund, A. M., Simmons, E. H., Aceves, C. M., Anderson, C., Gangavarapu, K., Hufbauer, E., Kurzban, E., Lee, J., Matteson, N. L., Parker, E., Perkins, S. A., Ramesh, K. S., Robles-Sikisaka, R., Schwab, M. A., Spencer, E., Wohl, S., Nicholson, L., Mchardy, I. H., Dimmock, D. P., Hobbs, C. A., Bakhtar, O., Harding, A., Mendoza, A., Bolze, A., Becker, D., Cirulli, E. T., Isaksson, M., Schiabor Barrett, K. M., Washington, N. L., Malone, J. D., Murphy Schafer, A., Gurfield, N., Stous, S., Fielding-Miller, R., Gaines, T., Garfein, R., Anderson, C. A. M., Martin, N. K., Schooley, R. T., Austin, B., Kingsmore, S. F., Lee, W., Shah, S., McDonald, E., Zeller, M., Fisch, K. M., Laurent, L. C., Yeo, G. W., Andersen, K. G., Knight, R.
10.1101/2021.12.21.21268143 — Posted: 2021-12-27
Comparative analysis of single cell lung atlas of bat, cat, tiger and pangolin
Wang, X., Ou, Z., Ding, P., Sun, C., Wang, D., Zhu, J., Wu, W., Wei, Y., Ding, X., Luo, L., Li, M., Zhang, W., Jin, X., Sun, J., Liu, H., Chen, D.
10.1101/2021.12.26.473325 — Posted: 2021-12-27
The SARS-CoV-2 nucleocapsid protein preferentially binds long and structured RNAs
Tai, C. E., Tayeb-Fligelman, E., Griner, S., Salwinski, L., Bowler, J. T., Abskharon, R., Cheng, X., Seidler, P. M., Jiang, Y. X., Eisenberg, D. S., Guo, F.
10.1101/2021.12.25.474155 — Posted: 2021-12-27
Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil
Cerqueira-Silva, T., Andrews, J. R., Boaventura, V. S., Ranzani, O. T., Oliveira, V. d. A., Paixao, E. S., Bertoldo, J., Machado, T. M., Hitchings, M. D. T., Dorion, M., Lind, M. L., Penna, G. O., Cummings, D. A. T., Dean, N. E., Werneck, G. L., Pearce, N., Barreto, M. L., Ko, A. I., Croda, J., Barral-Netto, M.
10.1101/2021.12.21.21268058 — Posted: 2021-12-27
Detection of the omicron variant virus with the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
Regan, J., Flynn, J., Choudhary, M., Uddin, R., Lemieux, J., Boucau, J., Bhattacharyya, R., Barczak, A. K., Li, J. Z. K., Siedner, M.
10.1101/2021.12.22.21268219 — Posted: 2021-12-27
Durability of Response to a Third BNT162b2 Vaccine in Adults >=60 Years
Eliakim Raz, N., Stemmer, A., Leibovici-Weissman, Y., Ness, A., Awwad, M., Ghantous, N., Erez, N., Bareket-Samish, A., Levy-Barda, A., Ben-Zvi, H., Moskovits, N., Bar-Haim, E., Stemmer, S.
10.1101/2021.12.25.21268336 — Posted: 2021-12-27
BNT162b2 boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
Behrens, G. M., Barros-Martins, J., Cossmann, A., Morillas Ramos, G., Stankov, M. V., Odak, I., Dopfer-Jablonka, A., Hetzel, L., Koehler, M., Patzer, G., Binz, C., Ritter, C., Friedrichsen, M., Schultze-Florey, C. R., Inga, R., Willenzon, S., Bubke, A., Rispenpart, J., Janssen, A., Ssebyatika, G., Bernhardt, G., Hoffmann, M. R., Poehlmann, S., Krey, T., Bosnjak, B., Hammerschmidt, S. I., Foerster, R.
10.1101/2021.12.25.21268392 — Posted: 2021-12-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).